Literature DB >> 22447319

Plasma midregional proadrenomedullin in newborn infants: impact of prematurity and perinatal infection.

Deborah Admaty1, Jörg Benzing, Tilo Burkhardt, Olav Lapaire, Lukas Hegi, Gabor Szinnai, Nils G Morgenthaler, Hans Ulrich Bucher, Christoph Bührer, Sven Wellmann.   

Abstract

INTRODUCTION: Adrenomedullin (ADM) is one of the strongest endogenous vasodilating hormones. Its stable by-product midregional-proADM (MR-proADM) is an established indicator of systemic infection and cardiovascular compromise in adult patients.
METHODS: A prospective cross-sectional study was performed to investigate the perinatal factors affecting MR-proADM plasma concentrations in 328 newborn infants with a gestational age (GA) between 24 and 41 wk.
RESULTS: Blood samples were obtained in 270 infants from umbilical veins (with additional 108 paired samples from umbilical arteries), and at 2-3 d of life in 183 infants. Paired venous and arterial umbilical cord MR-proADM concentrations were closely related (Spearman's rank order correlation coefficient (R(s)) = 0.825, P < 0.001). MR-proADM concentrations at birth and at 2-3 d were inversely related to GA (R(s) = -0.403 and R(s) = -0.541, respectively) and birth weight (BW; R(s) = -0.421 and R(s) = -0.530, respectively; all P < 0.001). On stepwise regression analysis, clinical chorioamnionitis and umbilical arterial blood base excess retained a significant impact on MR-proADM cord venous blood concentrations. At 2-3 d of life, histologic chorioamnionitis and GA at delivery were significantly associated with MR-proADM levels. DISCUSSION: As compared with adults, MR-proADM concentrations are elevated in neonates, especially those born very preterm. Immaturity and infection, which both feature low systemic vascular resistance, are related to increased MR-proADM concentrations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447319     DOI: 10.1038/pr.2012.38

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Mid-regional pro-adrenomedullin for diagnosing evolution after cardiac surgery in newborns: the PRONEW study.

Authors:  Sara Bobillo-Perez; Monica Girona-Alarcon; Debora Cañizo; Marta Camprubi-Camprubi; Javier Rodriguez-Fanjul; Monica Balaguer; Sergio Benito; Anna Valls; Francisco Jose Cambra; Iolanda Jordan
Journal:  Eur J Pediatr       Date:  2021-10-22       Impact factor: 3.183

Review 2.  Proadrenomedullin and neonatal sepsis: a systematic review and meta-analysis of diagnostic accuracy.

Authors:  Gerasimos Panagiotis Milas; Vasileios Issaris
Journal:  Eur J Pediatr       Date:  2021-08-03       Impact factor: 3.183

3.  Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis.

Authors:  Sameh Samir Fahmey; Heba Mostafa; Noha Abd Elhafeez; Heba Hussain
Journal:  Korean J Pediatr       Date:  2018-05-28

4.  Diagnostic and Prognostic Validity of Proadrenomedullin among Neonates with Sepsis in Tertiary Care Hospitals of Southern India.

Authors:  Raja Kannan; Suchetha S Rao; Prasanna Mithra; B Dhanashree; Shantharam Baliga; Kamalakshi G Bhat
Journal:  Int J Pediatr       Date:  2018-08-01

5.  MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children.

Authors:  Rafael Peñalver Penedo; Marta Rupérez Lucas; Luis Antonio Álvarez-Sala Walther; Alicia Torregrosa Benavent; María Luisa Casas Losada; Luis Bañuelos Andrio; Ana Belén Rebolledo Poves; Mercedes Bueno Campaña
Journal:  BMC Pediatr       Date:  2021-06-29       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.